50 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

3759

Pharmaron Beijing
CN¥9.450%-53.3%CN¥33.5bCN¥11.34PE24.2xE15.4%1.0%

2877

China Shineway Pharmaceutical Group
HK$7.88-4.3%n/aHK$6.0bHK$13.88PE5.8xE14.5%7.2%

6826

Shanghai Haohai Biological Technology
HK$29.80-2.1%27.0%HK$14.9bHK$33.90PE12.2xE18.2%2.4%

1521

Frontage Holdings
HK$1.00-2.0%-55.6%HK$2.1bHK$1.70PE24xE26.1%n/a

9926

Akeso
HK$40.10-1.4%7.1%HK$34.7bHK$59.42PE15.8xE9.6%n/a

6600

SciClone Pharmaceuticals (Holdings)
HK$18.56-0.4%70.3%HK$11.3bHK$17.86PE9.3xE4.7%0%

9926

Akeso
HK$39.85-2.0%6.4%HK$34.7bHK$59.05PE15.8xE9.6%n/a

2005

SSY Group
HK$4.881.9%-5.1%HK$13.7bHK$6.23PE11xE15.0%3.5%

512

Grand Pharmaceutical Group
HK$4.83-0.8%6.2%HK$16.9bn/aPE9xE13.9%5.4%

6826

Shanghai Haohai Biological Technology
HK$31.403.1%33.8%HK$14.9bHK$35.72PE12.2xE18.2%2.4%

2005

SSY Group
HK$4.62-3.5%-10.1%HK$13.7bHK$5.89PE11xE15.0%3.5%

1521

Frontage Holdings
HK$1.031.0%-54.2%HK$2.1bHK$1.75PE24xE26.1%n/a

3759

Pharmaron Beijing
CN¥9.955.3%-50.8%CN¥33.5bCN¥11.94PE24.2xE15.4%1.0%

3759

Pharmaron Beijing
CN¥9.955.3%-50.8%CN¥33.5bCN¥11.94PE24.2xE15.4%1.0%

512

Grand Pharmaceutical Group
HK$4.82-1.0%5.9%HK$16.9bn/aPE9xE13.9%5.4%

2005

SSY Group
HK$4.62-3.5%-10.1%HK$13.7bHK$5.89PE11xE15.0%3.5%

2696

Shanghai Henlius Biotech
HK$18.840%63.5%HK$10.2bHK$18.03PE17.4xE15.8%n/a

3347

Hangzhou Tigermed Consulting
CN¥32.45-0.9%-37.9%CN¥46.1bCN¥44.77PE27.5xE18.7%1.1%

3347

Hangzhou Tigermed Consulting
CN¥30.65-6.4%-41.3%CN¥46.1bCN¥42.29PE27.5xE18.7%1.1%

3347

Hangzhou Tigermed Consulting
CN¥32.45-0.9%-37.9%CN¥46.1bCN¥44.77PE27.5xE18.7%1.1%

6821

Asymchem Laboratories (Tianjin)
CN¥52.40-1.1%-48.3%CN¥26.2bCN¥69.39PE13.8xE4.6%2.4%

13

HUTCHMED (China)
UK£29.653.0%40.5%UK£2.5bUK£46.62PE32xE18.0%n/a

13

HUTCHMED (China)
UK£29.653.0%40.5%UK£2.5bUK£46.62PE32xE18.0%n/a

6821

Asymchem Laboratories (Tianjin)
CN¥52.75-0.5%-47.9%CN¥26.2bCN¥69.85PE13.8xE4.6%2.4%
Page 2 of 3
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.